Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co's Dr Daniel Pascheles joins Molekule Consulting

He becomes the biopharma services provider’s CEO

Molekule Consulting Dr Daniel PaschelesMiami, US-based Molekule Consulting has appointed Dr Daniel Pascheles as its new chief executive officer.

Dr Daniel Pascheles joins from Merck & Co, where he served as vice president and head of global competitive intelligence for the last 12 years.

While at Merck, Dr Pascheles provided strategy development, target and candidate identification for the firm's licensing, business development and M&A activities, alongside leading the CI department.

Prior to this, Dr Pascheles worked at Aventis Pharmaceuticals - as well as its predecessor companies - for over 14 years, latterly as its vice president.

His previous roles include head of global competitive intelligence, global marketing director, general manager of Switzerland and European head of sales, marketing administration and strategic planning.

David Alderman, Molekule Consulting's founder and president, said: “Dr Pascheles is one of the most experienced, ethical and well-respected CI professionals in our industry; he is a global leader who brings expertise and exceptional vision to build our growing company.”

6th January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics